| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 88.6319 | 73 |
| GSM780708 | Untreated after 4 days (C2_1) | 83.1237 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 74.0471 | 70 |
| GSM780719 | Untreated after 4 days (C1_2) | 76.0997 | 71 |
| GSM780720 | Untreated after 4 days (C2_2) | 81.9246 | 72 |
| GSM780721 | Untreated after 4 days (C3_2) | 71.1283 | 69 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 71.5828 | 70 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 79.034 | 71 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 87.1545 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.2696 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 90.6235 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 74.0187 | 70 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 88.7962 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 95.1288 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 82.0954 | 72 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 92.1799 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 82.6893 | 72 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 82.3881 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 95.017 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 70.7313 | 69 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 73.7079 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 86.3492 | 73 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 97.8641 | 75 |